Landscapes / Companies
AO GENERIUM not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 13 in all
Trials
2 active
21 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved in Russia | 20 Dec 2027Phase 2/3 trial completes | |||
| Next date | 20 Dec 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Mucopolysaccharidosis Type II, Metabolic Diseases | ||||
| Open drug page | |||||
GNR-139not checked |
— |
Phase 3 | May 2028Phase 3 trial completes | ||
| Next date | May 2028 · Phase 3 trial completes | ||||
| Also tested for | nAMD | ||||
| Open drug page | |||||
About
- No active trial
- 11 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021